Esmail A, Badheeb M, Alnahar B, Almiqlash B, Sakr Y, Khasawneh B
Cancers (Basel). 2024; 16(11).
PMID: 38893067
PMC: 11171350.
DOI: 10.3390/cancers16111946.
Balogun O, Atoyebi O
J West Afr Coll Surg. 2022; 12(3):111-119.
PMID: 36388748
PMC: 9641745.
DOI: 10.4103/jwas.jwas_22_22.
Kingham T, Aveson V, Wei A, Castellanos J, Allen P, Nussbaum D
Curr Probl Surg. 2021; 58(2):100854.
PMID: 33531120
PMC: 8022290.
DOI: 10.1016/j.cpsurg.2020.100854.
Song B, Cha B, Park J, Jeong S, Lee D
Medicine (Baltimore). 2020; 99(52):e23668.
PMID: 33350747
PMC: 7769315.
DOI: 10.1097/MD.0000000000023668.
Turgeon M, Maithel S
Chin Clin Oncol. 2019; 9(1):4.
PMID: 31500433
PMC: 7186525.
DOI: 10.21037/cco.2019.08.09.
The Importance of Imaging Techniques in the Assessment of Biliary Tract Cancer.
Florescu L, Florescu D, Gheonea I
Curr Health Sci J. 2019; 43(3):201-208.
PMID: 30595876
PMC: 6284837.
DOI: 10.12865/CHSJ.43.03.03.
Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
Lin G, Lin K, Wang F, Chen T, Yen T, Yeh T
Dis Model Mech. 2018; 11(8).
PMID: 29666220
PMC: 6124555.
DOI: 10.1242/dmm.033050.
A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma.
Zheng B, Yang L, Sun Q, Fan H, Duan M, Shi J
Clin Transl Gastroenterol. 2017; 8(10):e118.
PMID: 28981082
PMC: 5666116.
DOI: 10.1038/ctg.2017.45.
CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma.
Coelho R, Silva M, Rodrigues-Pinto E, Cardoso H, Lopes S, Pereira P
GE Port J Gastroenterol. 2017; 24(3):114-121.
PMID: 28848795
PMC: 5553366.
DOI: 10.1159/000452691.
Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
Golan T, Raitses-Gurevich M, Kelley R, Bocobo A, Borgida A, Shroff R
Oncologist. 2017; 22(7):804-810.
PMID: 28487467
PMC: 5507643.
DOI: 10.1634/theoncologist.2016-0415.
Hepatobiliary Tumors: Update on Diagnosis and Management.
Kabbach G, Assi H, Bolotin G, Schuster M, Lee H, Tadros M
J Clin Transl Hepatol. 2015; 3(3):169-81.
PMID: 26623263
PMC: 4663198.
DOI: 10.14218/JCTH.2015.00012.
Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.
Yang S, Lin H, Chang V, Chen C, Liu Y, Wang J
Oncotarget. 2015; 6(27):23857-73.
PMID: 26160843
PMC: 4695157.
DOI: 10.18632/oncotarget.4408.
Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy.
Bertani H, Frazzoni M, Mangiafico S, Caruso A, Manno M, Mirante V
World J Gastrointest Endosc. 2015; 7(6):582-92.
PMID: 26078827
PMC: 4461933.
DOI: 10.4253/wjge.v7.i6.582.
Optimum chemotherapy for the management of advanced biliary tract cancer.
Ghosn M, Kourie H, El Rassy E, Chebib R, El Karak F, Hanna C
World J Gastroenterol. 2015; 21(14):4121-5.
PMID: 25892861
PMC: 4394072.
DOI: 10.3748/wjg.v21.i14.4121.
Imaging of malignancies of the biliary tract- an update.
Hennedige T, Neo W, Venkatesh S
Cancer Imaging. 2015; 14:14.
PMID: 25608662
PMC: 4331820.
DOI: 10.1186/1470-7330-14-14.
Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.
Rustagi T, Dasanu C
J Gastrointest Cancer. 2011; 43(2):137-47.
PMID: 21597894
DOI: 10.1007/s12029-011-9284-y.
Adjuvant radiotherapy for gallbladder cancer: a dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy.
Sun X, Wang Q, Gu B, Zhu Y, Hu J, Shi G
World J Gastroenterol. 2011; 17(3):397-402.
PMID: 21253402
PMC: 3022303.
DOI: 10.3748/wjg.v17.i3.397.
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
Benson 3rd A, Abrams T, Ben-Josef E, Bloomston P, Botha J, Clary B
J Natl Compr Canc Netw. 2009; 7(4):350-91.
PMID: 19406039
PMC: 4461147.
DOI: 10.6004/jnccn.2009.0027.
Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma.
Baisden J, Kahaleh M, Weiss G, Sanfey H, Moskaluk C, Yeaton P
Gastrointest Cancer Res. 2009; 2(5):219-24.
PMID: 19259306
PMC: 2632558.
Diagnosis of biliary tract and ampullary carcinomas.
Tsukada K, Takada T, Miyazaki M, Miyakawa S, Nagino M, Kondo S
J Hepatobiliary Pancreat Surg. 2008; 15(1):31-40.
PMID: 18274842
PMC: 2794353.
DOI: 10.1007/s00534-007-1278-6.